Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

9431 ARTÍCULOS , VIENDO DEL 3706 AL 3720

Sleep disorders in aging polio survivors: A systematic review

Léotard A, Lévy J, Hartley S, Pages A, Genet F, Lofaso F, Prigent H, Quera-Salva MA.

Ann Phys Rehabil Med. 2020 Nov;63(6):543-553. doi: 10.1016/j.rehab.2019.10.007. Epub 2019 Nov 30.

Exercise as a favorable non-pharmacologic treatment to Sleep-Related Movement Disorders: a review

Franco B, Daubian-Nosé P, De-Mello MT, Esteves AM.

Sleep Sci. 2019 Apr-Jun;12(2):116-121. doi: 10.5935/1984-0063.20190064.

Mesenchymal stem cell transplantation and aerobic exercise for Parkinson's disease: therapeutic assets beyond the motor domain

Berrío Sánchez J, Cucarian Hurtado J, Barcos Nunes R, de Oliveira AA.

Rev Neurosci. 2019 Jan 28;30(2):165-178. doi: 10.1515/revneuro-2018-0011.

Two-Year Agility Maintenance Training Slows the Progression of Parkinsonian Symptoms

Tollár J, Nagy F, Kovács N, Hortobágyi T.

Med Sci Sports Exerc. 2019 Feb;51(2):237-245. doi: 10.1249/MSS.0000000000001793.

Qualitative Evaluation of the Personal KinetiGraphTM Movement Recording System in a Parkinson's Clinic

Santiago A, Langston JW, Gandhy R, Dhall R, Brillman S, Rees L, Barlow C.

J Parkinsons Dis. 2019;9(1):207-219. doi: 10.3233/JPD-181373.

Multidisciplinary care for people with Parkinson's disease: the new kids on the block!

Radder DLM, de Vries NM, Riksen NP, Diamond SJ, Gross D, Gold DR, Heesakkers J, Henderson E, Hommel ALAJ, Lennaerts HH, Busch J, Dorsey RE, Andrejack J, Bloem BR.

Expert Rev Neurother. 2019 Feb;19(2):145-157. doi: 10.1080/14737175.2019.1561285. Epub 2019 Jan 9.

Autonomic dysfunction in Parkinson disease and animal models

Metzger JM, Emborg ME.

Clin Auton Res. 2019 Aug;29(4):397-414. doi: 10.1007/s10286-018-00584-7. Epub 2019 Jan 2.

Effects of robot-assisted gait training in patients with Parkinson's disease: study protocol for a randomized controlled trial

Kang MG, Yun SJ, Shin HI, Kim E, Lee HH, Oh BM, Seo HG.

Trials. 2019 Jan 7;20(1):15. doi: 10.1186/s13063-018-3123-4.

The usual suspects, dopamine and alpha-synuclein, conspire to cause neurodegeneration

Mor DE, Daniels MJ, Ischiropoulos H.

Mov Disord. 2019 Feb;34(2):167-179. doi: 10.1002/mds.27607. Epub 2019 Jan 11.

Utility of Neuronal-Derived Exosomes to Examine Molecular Mechanisms That Affect Motor Function in Patients With Parkinson Disease: A Secondary Analysis of the Exenatide-PD Trial

Athauda D, Gulyani S, Karnati HK, Li Y, Tweedie D, Mustapic M, Chawla S, Chowdhury K, Skene SS, Greig NH, Kapogiannis D, Foltynie T.

JAMA Neurol. 2019 Apr 1;76(4):420-429. doi: 10.1001/jamaneurol.2018.4304.

Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review

Seppi K, Ray Chaudhuri K, Coelho M, Fox SH, Katzenschlager R, Perez Lloret S, Weintraub D, Sampaio C; the collaborators of the Parkinson's Disease Update on Non-Motor Symptoms Study Group on behalf of the Movement Disorders Society Evidence-Based Medicine Committee.

Mov Disord. 2019 Feb;34(2):180-198. doi: 10.1002/mds.27602. Epub 2019 Jan 17.

Gut-brain axis and the spread of α-synuclein pathology: Vagal highway or dead end?

Breen DP, Halliday GM, Lang AE.

Mov Disord. 2019 Mar;34(3):307-316. doi: 10.1002/mds.27556. Epub 2019 Jan 17.

Land Plus Aquatic Therapy Versus Land-Based Rehabilitation Alone for the Treatment of Freezing of Gait in Parkinson Disease: A Randomized Controlled Trial

Clerici I, Maestri R, Bonetti F, Ortelli P, Volpe D, Ferrazzoli D, Frazzitta G.

Phys Ther. 2019 May 1;99(5):591-600. doi: 10.1093/ptj/pzz003.

Suicide in Parkinson's disease

Shepard MD, Perepezko K, Broen MPG, Hinkle JT, Butala A, Mills KA, Nanavati J, Fischer NM, Nestadt P, Pontone G.

J Neurol Neurosurg Psychiatry. 2019 Jul;90(7):822-829. doi: 10.1136/jnnp-2018-319815. Epub 2019 Jan 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias